Edition:
United Kingdom

Jiang Zhong Pharmaceutical Co Ltd (600750.SS)

600750.SS on Shanghai Stock Exchange

25.30CNY
26 Apr 2018
Change (% chg)

-- (--)
Prev Close
¥25.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,609,798
52-wk High
¥23.09
52-wk Low
¥16.01

Latest Key Developments (Source: Significant Developments)

China Resources Pharmaceutical Group Updates On Buying Controlling Stake In Jiangzhong Group
Monday, 4 Jun 2018 

June 4 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UPDATES ON RESTRUCTURE WHEREBY CO WILL ACQUIRE CONTROLLING STAKE IN JIANGZHONG GROUP.OFFER PRICE OF FOR GENERAL OFFER FOR JIANGZHONG PHARMACEUTICAL CO SHALL BE RMB25.03 PER SHARE.TOTAL MAXIMUM CAPITAL AMOUNT NEEDED FOR OFFER IS RMB4.28 BILLION.NUMBER OF SHARES SUBJECT TO OFFER IS 170.9 MILLION LISTED TRADABLE SHARES OF JIANGZHONG PHARMACEUTICAL.COMPLETION OF PROPOSED ACQUISITION WILL TRIGGER OBLIGATION OF GENERAL OFFER FOR SHARES OF JIANGZHONG PHARMA.  Full Article

Jiang Zhong Pharmaceutical Says Owner's Proposal May Lead To Change Of Company's Ownership
Tuesday, 15 May 2018 

May 15 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS OWNER'S PROPOSAL MAY LEAD TO CHANGE OF CO'S OWNERSHIP, TRADING IN SHARES REMAINS SUSPENDED.  Full Article

Jiang Zhong Pharmaceutical's Chairman And General Manager Zhong Hongguang Retires
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS ITS CHAIRMAN AND GENERAL MANAGER ZHONG HONGGUANG RETIRES.  Full Article

Jiang Zhong Pharmaceutical's Prelim 2017 Net Profit Up 10 Percent Y/Y
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS PRELIM 2017 NET PROFIT UP 10 PERCENT Y/Y AT 418.0 MILLION YUAN ($65.38 million).  Full Article

HK's CR Pharma mulls $667 million general offer for Jiangzhong Pharma

HONG KONG China Resources Pharmaceutical Group Ltd said on Monday it would make a 4.28 billion yuan ($667 million) general offer for all outstanding shares of Jiangzhong Pharmaceutical Co Ltd after a deal to buy control of its parent.